Successful use of ketamine for intractable cancer pain

scientific article published on 6 October 2004

Successful use of ketamine for intractable cancer pain is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1015916140
P356DOI10.1007/S00520-004-0684-4
P8608Fatcat IDrelease_5vcjs7brh5cchf3hvuzhz27eqq
P698PubMed publication ID15480820

P2093author name stringJean-Jacques Body
Dominique A Lossignol
Myriam Obiols-Portis
P2860cites workEvidence of a role for NMDA receptors in pain perceptionQ28253098
Breakthrough pain: definition, prevalence and characteristicsQ33435886
Ketamine--its pharmacology and therapeutic uses.Q34272894
Intraventricular morphine administration for control of chronic cancer painQ39237699
Low-dose ketamine in the management of opioid nonresponsive terminal cancer painQ39440047
When all else fails: stepwise multiple solutions for a complex cancer pain syndromeQ39441928
Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective studyQ39471539
Pitfalls in the use of opiates in treatment of cancer painQ39491522
Comparison of ketamine and pethidine in experimental and postoperative painQ41350025
Analgesic and cognitive effects of intravenous ketamine-alfentanil combinations versus either drug alone after intradermal capsaicin in normal subjectsQ42541818
The treatment of cancer painQ43074092
The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal hornQ43499579
Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic mononeuropathyQ46159568
Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects.Q51590011
Response of chronic neuropathic pain syndromes to ketamine: a preliminary study.Q51644389
The Edmonton staging system for cancer pain: preliminary report.Q52266786
Intrathecal administration of high-dose morphine solutions decreases the pH of cerebrospinal fluidQ71981382
NMDA receptor antagonists: interactions with opioidsQ73133273
P433issue3
P304page(s)188-193
P577publication date2004-10-06
P1433published inSupportive Care in CancerQ15766919
P1476titleSuccessful use of ketamine for intractable cancer pain
P478volume13